Patent ID: 6867202
Filing Date: 2005-03-15
Classification: A61K,A61P,C07D,Y02P

Abstract:
1. A method for treating insulin resistance in a mammal, which comprises administering to said mammal an effective amount of a compound of formula I or the stereoisomeric mixtures, diastereomerically enriched, diastereomerically pure, enantiomerically enriched or enantiomerically pure isomers, or the pharmaceutically acceptable salts and prodrugs thereof, wherein e is 0 or 1; n and w are each independently 0, 1 or 2; provided that w and n cannot both be 0 at the same time; Y is oxygen or sulfur; R R R R X R or the carbon bearing X or X or X Z R R A r for each occurrence is independently 1, 2 or 3; X X X when there are two X m for each occurrence is independently 0, 1 or 2; with the proviso that: X when R